|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61P 25/28 |
| (11) | Number of the document | 2906696 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13846313.8 |
| Date of filing the European patent application | 2013-10-15 | |
| (97) | Date of publication of the European application | 2015-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/065067 |
| Date | 2013-10-15 |
| (87) | Number | WO 2014/062686 |
| Date | 2014-04-24 |
| (30) | Number | Date | Country code |
| 201261714139 P | 2012-10-15 | US |
| (72) |
RIGO, Frank, ES
CLEVELAND, Don W., US
LAGIER-TOURENNE, Clotilde, US
RAVITS, John M., US
BENNETT, C. Frank, US
FREIER, SUSAN M., US
BAUGHN, Michael W., US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 5th Floor, Oakland, CA 94607-5200,
US
Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad, CA 92010, US Ludwig Institute for Cancer Research, 666 Third Avenue, New York, NY 10017, US |
| (54) | METHODS FOR MODULATING C9ORF72 EXPRESSION |
| METHODS FOR MODULATING C9ORF72 EXPRESSION |